
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.
SSE:688505.SS
8.58 (CNY) • At close June 6, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities: | |||||||||||||||||||
Net Income
| 39.434 | 108.627 | 137.272 | 212.381 | 164.259 | 220.654 | 143.07 | 70.496 | 150.838 | 145.95 | 128.099 | 98.946 | 57.7 | 37.627 | 3.986 | -7.595 | -23.13 | -28.947 | -21.757 |
Depreciation & Amortization
| 82.22 | 62.232 | 80.97 | 60.853 | 53.611 | 56.676 | 53.217 | 42.607 | 30.114 | 28.298 | 24.393 | 14.838 | 9.786 | 5.354 | 7.724 | 5.303 | 6.171 | 6.865 | 6.134 |
Deferred Income Tax
| -32.41 | -14.97 | -6.679 | -22.687 | -4.793 | -16.655 | -36.534 | -0.059 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Stock Based Compensation
| 0 | -1.843 | 7.689 | 64.974 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Change In Working Capital
| -114.422 | -122.992 | -60.286 | -48.632 | -103.804 | -17.249 | -19.313 | -51.923 | -11.131 | -55.215 | -42.849 | -10.637 | 45.36 | 3.404 | -14.071 | 8.827 | -3.868 | 2.136 | -7.086 |
Accounts Receivables
| 114.05 | -10.475 | -89.73 | -95.37 | -83.538 | -122.901 | -206.109 | -26.694 | 1.431 | -53.522 | -19.586 | 10.086 | -25.671 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventory
| -5.859 | -6.572 | -5.841 | 0.318 | -5.415 | -4.328 | 6.97 | -16.024 | -13.728 | 5.612 | 0.111 | -9.06 | 0.779 | -5.355 | -2.087 | -3.338 | -4.361 | -5.884 | -0.964 |
Accounts Payables
| -236.305 | -74.055 | 48.719 | 72.561 | -2.541 | 134.118 | 211.969 | -9.129 | 7.727 | -0.481 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Working Capital
| 13.693 | -31.89 | -13.434 | -26.141 | -12.31 | -24.139 | -26.283 | -35.899 | 2.597 | -60.827 | -42.96 | -1.577 | 44.581 | 8.759 | -11.984 | 12.165 | 0.493 | 8.02 | -6.122 |
Other Non Cash Items
| 10.407 | 39.961 | 6.303 | 2.012 | -1.063 | 9.152 | -3.035 | -18.469 | -29.247 | -22.737 | -21.284 | -13.705 | -2.658 | 3.204 | -4.747 | 1.189 | 4.937 | 2.761 | 1.31 |
Operating Cash Flow
| -14.77 | 71.015 | 165.269 | 268.9 | 113.003 | 269.233 | 173.939 | 42.711 | 140.574 | 96.296 | 88.359 | 89.442 | 110.188 | 49.589 | -7.108 | 7.724 | -15.89 | -17.185 | -21.399 |
Investing Activities: | |||||||||||||||||||
Investments In Property Plant And Equipment
| -42.669 | -98.968 | -87.304 | -120.116 | -42.411 | -40.386 | -37.789 | -60.941 | -46.822 | -39.748 | -44.905 | -57.376 | -114.694 | -32.988 | -9.406 | -55.816 | -2.916 | -6.275 | -16.865 |
Acquisitions Net
| 0 | 0 | 1.442 | -259.62 | -36 | 6.796 | -24 | 0.015 | 0.037 | -22.691 | -0.271 | 0.572 | -0.053 | 0.014 | 0 | 0.025 | 0.156 | 0 | 0 |
Purchases Of Investments
| -3,892 | -3,909 | -4,029 | -3,485.759 | -3,085.1 | -1,660 | -1,869.9 | -1,620.675 | -1,295.55 | -1,767.523 | -1,411.817 | -422.4 | -4.757 | -3.422 | -7.868 | -6.568 | -10.627 | 0 | 0 |
Sales Maturities Of Investments
| 3,910.147 | 3,961.913 | 4,018.115 | 3,242.158 | 3,104.949 | 1,669.829 | 1,881.968 | 1,619.105 | 1,302.133 | 1,776.816 | 1,418.59 | 424.552 | 5.669 | 4.437 | 8.147 | 11.364 | 6.199 | 0.432 | 0.717 |
Other Investing Activites
| 0.641 | 0.678 | -10.885 | 267.666 | 12.026 | 2.618 | 1.091 | -2.069 | -6.995 | -8.726 | -3.786 | -3.903 | -1.093 | -3.196 | 11.312 | 0.002 | 6.206 | -4.75 | 1.435 |
Investing Cash Flow
| -23.882 | -45.377 | -96.748 | -355.671 | -46.535 | -21.142 | -48.63 | -64.565 | -47.197 | -61.872 | -42.189 | -58.555 | -114.928 | -35.155 | 2.185 | -50.993 | -0.982 | -10.593 | -14.713 |
Financing Activities: | |||||||||||||||||||
Debt Repayment
| 0 | -100 | -9.516 | 0 | -5.313 | -6.204 | 10 | 20 | -5 | 89.7 | -15 | -86.498 | 49.838 | 5.33 | -1.67 | 12 | 10 | 10 | 31 |
Common Stock Issued
| 0 | 66.862 | 0 | 48.326 | 996.19 | 0 | 0 | 0 | 0 | 0 | 0 | 225.963 | 0 | 0 | 0 | 68.816 | 0 | 0 | 0 |
Common Stock Repurchased
| 0 | 0 | -8.7 | -40.824 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Dividends Paid
| -93.291 | -76.152 | -72.03 | -52.15 | -64.61 | -64.61 | -27.69 | -46.15 | -27.986 | -45.854 | 0 | -3.692 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Financing Activities
| -7.982 | 57.175 | 100.862 | -49.014 | -167.263 | -183.167 | 6.491 | 5.165 | 4.99 | 11.63 | 0 | 0 | 3.1 | 0 | 10 | 0 | 30 | 0 | 0 |
Financing Cash Flow
| -101.273 | -118.977 | 11.608 | -101.164 | 753.847 | -259.569 | -5.396 | -20.985 | -27.996 | 55.476 | -15 | 135.773 | 52.938 | 5.33 | 8.33 | 80.816 | 40 | 10 | 31 |
Other Information: | |||||||||||||||||||
Effect Of Forex Changes On Cash
| 0 | -0.068 | 0.293 | -0.074 | -0.224 | 0.056 | 0.164 | -0.301 | -0.094 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.057 | -0.122 | -0.463 |
Net Change In Cash
| 0 | -93.407 | 80.422 | -188.009 | 820.091 | -11.422 | 120.077 | -43.14 | 65.287 | 89.9 | 31.17 | 166.66 | 48.198 | 19.764 | 3.407 | 37.547 | 23.071 | -17.9 | -5.575 |
Cash At End Of Period
| 1,056.286 | 1,195.896 | 1,289.303 | 1,208.881 | 1,396.89 | 576.799 | 588.221 | 468.144 | 511.284 | 445.997 | 356.097 | 324.927 | 158.267 | 110.069 | 90.305 | 86.898 | 49.351 | 26.28 | 44.18 |